GlassScriptPhysician profile
Steven E Morton
NPI 1932104767
$5,908.58
in general payments reported to CMS, 2019-2025
39 companies · $107 in 2025
The $107 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,232 · 2020: $629 · 2021: $1,200 · 2022: $1,276 · 2023: $1,200 · 2024: $264 · 2025: $107.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,549 · Education: $21.70.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,549.02 |
| Education | $21.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $649.76 | 2019-2023 | Verquvo, Belsomra, Steglatro |
| Pfizer INC. | $587.21 | 2019-2025 | |
| Astellas Pharma US INC | $547.51 | 2019-2023 | Myrbetriq, Veozah |
| Lilly USA, LLC | $493.01 | 2019-2023 | Mounjaro, Trulicity, Jardiance |
| Astrazeneca Pharmaceuticals LP | $400.14 | 2019-2023 | Farxiga, Breztri |
| Novo Nordisk INC | $391.83 | 2019-2023 | Ozempic, Rybelsus |
| Novartis Pharmaceuticals Corporation | $340.85 | 2019-2023 | |
| Abbott Laboratories | $323.45 | 2021-2023 | Freestyle Libre 3, Freestyle Libre 2 |
| Abbvie INC. | $315.13 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $209.99 | 2020-2023 | Spravato |
| Amarin Pharma, INC. | $190.31 | 2019-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $174.52 | 2019-2023 | Xifaxan |
| Amgen INC. | $158.90 | 2019-2025 | Otezla, Repatha, Tezspire |
| Seqirus USA INC | $154.15 | 2024 | Fluad, Flucelvax |
| Alexion Pharmaceuticals, INC. | $118.57 | 2019-2022 |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Morton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.